Influence of SEN virus on the response to a combination therapy in patients with chronic HCV infection

被引:0
|
作者
Sagir, A
Ortwin, A
Oliver, K
Andreas, E
Tobias, H
Dieter, H
机构
[1] Uniklin, Klin Gastroenterol Hepatol & Infekt, Dusseldorf, Germany
[2] Uniklin, Inst Virol, Dusseldorf, Germany
关键词
D O I
10.1016/S0168-8278(03)80844-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
578
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [41] Response to antiviral therapy predicts the development of glucose abnormalities in patients with chronic HCV genotype 4 infection
    Chehadeh, W.
    Al-Nakib, W.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S31 - S31
  • [42] Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
    Pianko, S
    McHutchison, JG
    Gordon, SC
    Heaton, S
    Goodman, ZD
    Blatt, LM
    Cortese, CM
    Bacon, B
    HEPATOLOGY, 2000, 32 (04) : 371A - 371A
  • [43] Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy
    Toyoda, H
    Kumada, T
    Kiriyama, S
    Sone, Y
    Tanikawa, M
    Hisanaga, Y
    Kuzuya, T
    Honda, T
    Hayashi, K
    Nakano, I
    Katano, Y
    Goto, H
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (06) : E49 - E54
  • [44] Methadone therapy is associated with a reduced risk of chronic hepatitis C virus (HCV) infection in patients who are positive for HCV antibody.
    Clarkston, WK
    Debroy, RK
    Quiason, SG
    Alba, LM
    Cuddy, AG
    Snowden, JC
    Smith, OJ
    Pandya, PK
    GASTROENTEROLOGY, 2000, 118 (04) : A952 - A952
  • [45] SEN virus infection in patients with chronic hepatitis C: Preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin
    Kao, JH
    Chen, W
    Chen, PJ
    Lai, MY
    Chen, DS
    Chen, S
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (02): : 307 - 310
  • [46] Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection
    Hoofnagle, Jay H.
    Wahed, Abdus S.
    Brown, Robert S., Jr.
    Howell, Charles D.
    Belle, Steven H.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08): : 1112 - 1120
  • [47] The case for combination antiviral therapy for chronic hepatitis B virus infection
    Nash, Kathryn L.
    Alexander, Graeme J. M.
    LANCET INFECTIOUS DISEASES, 2008, 8 (07): : 444 - 448
  • [48] Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
    Iacobellis, Angelo
    Andriulli, Angelo
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1929 - 1938
  • [49] The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection
    Persico, Marcello
    Bruno, Savino
    Costantino, Andrea
    Mazza, Marta
    Almasio, Piero Luigi
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2011, 2011
  • [50] Combination therapy with interferon alpha and ribavirin for hepatitis C virus (HCV) infection in multiply transfused thalassaemic patients.
    Telfer, PT
    Whitby, K
    Grant, P
    Garson, JA
    Hoffbrand, AV
    Wonke, B
    BLOOD, 1996, 88 (10) : 2096 - 2096